Target intelligence / Profile preview

Transmembrane emp24 domain-containing protein 7 (TMED7)

Target
TMED7
Molecular classification
Other (p24 family/cargo receptor), Protein transport/trafficking protein
01

Overview

Transmembrane emp24 domain-containing protein 7 (TMED7) is a member of the p24/TMED protein family, characterized by a single transmembrane domain and a luminal Golgi-dynamics (GOLD) domain[5][2]. TMED7 is primarily localized to the Golgi apparatus and endoplasmic reticulum-Golgi intermediate compartment, where it plays a key role in vesicular trafficking and cargo selection as part of the early secretory pathway[3][5]. It regulates the biosynthesis, processing, and post-translational modification of secreted proteins, functioning as a cargo receptor and participating in quality control of protein folding[3][5]. Additionally, TMED7 is involved in the negative regulation of toll-like receptor 4 (TLR4) signaling upon lipopolysaccharide stimulation, influencing innate immune responses by facilitating degradation of TLR4 and inhibiting specific (MyD88-independent) downstream pathways[2]. TMED7, like other TMED family members, may also have broader roles in disease, including congenital glycosylation disorders, cancer, inflammation, and neurodegenerative disease, by influencing protein trafficking and immune signaling[5][3][2]. No known drugs or targeted inhibitors are currently associated with TMED7.

Other names
Transmembrane p24 trafficking protein 7CGI-109p24gamma3FLJ90481p24g3p24 family protein gamma-3p27Tagtransmembrane emp24 protein transport domain containing 7
02

Biological functions

Vesicular protein trafficking (early secretory pathway, ER-Golgi transport)Golgi organizationEndoplasmic reticulum to Golgi vesicle-mediated transportIntracellular protein transportNegative regulation of Toll-like receptor 4 (TLR4) signaling (immune response)
03

Disease associations

Cancer (associations described for TMED family)[5]Inflammation (via innate immunity modulation)[2]Congenital disorder of glycosylation, type Iy[3]Combined oxidative phosphorylation deficiency 8[3]Neurodegenerative disease (implicated more generally for the TMED family)[5]

Beyond the preview

Go deeper on Transmembrane emp24 domain-containing protein 7 (TMED7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane emp24 domain-containing protein 7 (TMED7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call